These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2522335)

  • 21. Ethanol- and diazepam-withdrawal hyperlocomotion is not due to 5-HT3 receptor stimulation.
    Mehta AK; Ticku MK
    Pharmacol Biochem Behav; 1993 Jul; 45(3):755-7. PubMed ID: 8332636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
    Costall B; Domeney AM; Farre AJ; Kelly ME; Martinez L; Naylor RJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):90-8. PubMed ID: 1352556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoradiography of [3H]quipazine in rodent brain.
    Perry DC
    Eur J Pharmacol; 1990 Oct; 187(1):75-85. PubMed ID: 2272355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT3 receptors antagonists reduce serotonin-induced scratching in mice.
    Ostadhadi S; Kordjazy N; Haj-Mirzaian A; Mansouri P; Dehpour AR
    Fundam Clin Pharmacol; 2015 Jun; 29(3):310-5. PubMed ID: 25711853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploration of mice in a black and white test box: validation as a model of anxiety.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Tomkins DM
    Pharmacol Biochem Behav; 1989 Mar; 32(3):777-85. PubMed ID: 2740429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tropisetron and ondansetron in mice forced swimming test and tail suspension test.
    Haj-Mirzaian A; Kordjazy N; Amiri S; Haj-Mirzaian A; Amini-Khoei H; Ostadhadi S; Dehpour A
    Eur J Pharmacol; 2016 Jun; 780():71-81. PubMed ID: 27001377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice.
    Kilfoil T; Michel A; Montgomery D; Whiting RL
    Neuropharmacology; 1989 Sep; 28(9):901-5. PubMed ID: 2572995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Astra Award Lecture. The psychopharmacology of 5-HT3 receptors.
    Costall B; Naylor RJ
    Pharmacol Toxicol; 1992 Dec; 71(6):401-15. PubMed ID: 1362267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 5-HT3 receptor antagonists ICS 205-930 and GR38032F, putative anxiolytic drugs, differ from diazepam in their pharmacological profile.
    Papp M; Przegalinski E
    J Psychopharmacol; 1989 Jan; 3(1):14-20. PubMed ID: 22156306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of tropisetron injected into the nucleus accumbens septi on ethanol consumption in rats.
    Jankowska E; Kostowski W
    Alcohol; 1995; 12(3):195-8. PubMed ID: 7639950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential analgesic actions of serotonin 5-HT3 receptor antagonists in the mouse.
    Giordano J; Dyche J
    Neuropharmacology; 1989 Apr; 28(4):423-7. PubMed ID: 2526302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat.
    Hagan RM; Jones BJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1990 Feb; 99(2):227-32. PubMed ID: 1691672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which type of 5-hydroxytryptamine receptor mediates relaxation of the longitudinal muscle of guinea pig proximal colon in vitro?
    Sevcík J; Ruzicka V; Slánsky J; Masek K
    Methods Find Exp Clin Pharmacol; 1996 Sep; 18(7):421-30. PubMed ID: 8900213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety.
    Onaivi ES; Martin BR
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):963-76. PubMed ID: 2573111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-HT3 receptors and the therapeutic potential of 5-HT3 receptor antagonists.
    Tyers MB
    Therapie; 1991; 46(6):431-5. PubMed ID: 1840227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of 5-hydroxytryptamine on external carotid nerve activity and its blockade by GR38032F in anesthetized rats.
    Yoshioka M; Ikeda T; Abe M; Togashi H; Saito H
    Res Commun Chem Pathol Pharmacol; 1991 Oct; 74(1):39-45. PubMed ID: 1839326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin and psychiatric disorders. A key to new therapeutic approaches.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
    Dupuis DS; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological characterization of 5-hydroxytryptamine-induced excitation of afferent cervical vagus nerve in anaesthetized rats.
    Yoshioka M; Ikeda T; Abe M; Togashi H; Minami M; Saito H
    Br J Pharmacol; 1992 Jul; 106(3):544-9. PubMed ID: 1387026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
    Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.